The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021
Open accessAbstract
(i.e., being fully vaccinated) was evaluated using a test-negative design comparing 20,101 immunocompromised adults (10,564 [53%] of whom were fully vaccinated) and 69,116 immunocompetent adults (29,456 [43%] of whom were fully vaccinated). VE of 2 doses of mRNA COVID-19 vaccine against COVID-19-associated hospitalization was lower among immunocompromised patients (77%; 95% confidence interval [CI] = 74%-80%) than among immunocompetent patients (90%; 95% CI = 89%-91%). This difference persisted irrespective of mRNA vaccine product, age group, and timing of hospitalization relative to SARS-CoV-2 (the virus that causes COVID-19) B.1.617.2 (Delta) variant predominance in the state of hospitalization. VE varied across immunocompromising condition subgroups, ranging from 59% (organ or stem cell transplant recipients) to 81% (persons with a rheumatologic or inflammatory disorder). Immunocompromised persons benefit from mRNA COVID-19 vaccination but are less protected from severe COVID-19 outcomes than are immunocompetent persons, and VE varies among immunocompromised subgroups. Immunocompromised persons receiving mRNA COVID-19 vaccines should receive 3 doses and a booster, consistent with CDC recommendations (5), practice nonpharmaceutical interventions, and, if infected, be monitored closely and considered early for proven therapies that can prevent severe outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674 · cited 3×
“Hematologic malignancy¶¶ (2,790) Unvaccinated 1,156 130 (11.”
Background
Cited by
Accorsi, E. K., Britton, A., Fleming-Dutra, K. E., Smith, Z. R., Shang, N., Derado, G., Miller, J., Schrag, S. J., & Verani, J. R. (2022) · JAMA · doi:10.1001/jama.2022.0470 · Cited by 628
Self-citationThompson, M. G., Natarajan, K., Irving, S. A., Rowley, E. A., Griggs, E. P., Gaglani, M., Klein, N. P., Grannis, S. J., DeSilva, M. B., Stenehjem, E., et al. (2022) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7104e3 · Cited by 398
Self-citationFerdinands, J. M., Rao, S., Dixon, B. E., Mitchell, P. K., DeSilva, M. B., Irving, S. A., Lewis, N., Natarajan, K., Stenehjem, E., Grannis, S. J., et al. (2022) · BMJ · doi:10.1136/bmj-2022-072141 · Cited by 185
Self-citationBouillon, K., Baricault, B., Botton, J., Jabagi, M.-J., Bertrand, M., Semenzato, L., Le Vu, S., Drouin, J., Dray-Spira, R., Weill, A., et al. (2022) · BMJ Medicine · doi:10.1136/bmjmed-2021-000104 · Cited by 31
Link-Gelles, R., Levy, M. E., Natarajan, K., Reese, S. E., Naleway, A. L., Grannis, S. J., Klein, N. P., DeSilva, M. B., Ong, T. C., Gaglani, M., et al. (2022) · doi:10.1101/2022.10.04.22280459 · Cited by 10
Self-citation
Metadata
- Authors
- Embi, P. J., Levy, M. E., Naleway, A. L., Patel, P., Gaglani, M., Natarajan, K., Dascomb, K., Ong, T. C., Klein, N. P., Liao, I.-C., Grannis, S. J., Han, J., Stenehjem, E., Dunne, M. M., Lewis, N., Irving, S. A., Rao, S., McEvoy, C., Bozio, C. H., Murthy, K., Dixon, B. E., Grisel, N., Yang, D.-H., Goddard, K., Kharbanda, A. B., Reynolds, S., Raiyani, C., Fadel, W. F., Arndorfer, J., Rowley, E. A., Fireman, B., Ferdinands, J., Valvi, N. R., Ball, S. W., Zerbo, O., Griggs, E. P., Mitchell, P. K., Porter, R. M., Kiduko, S. A., Blanton, L., Zhuang, Y., Steffens, A., Reese, S. E., Olson, N., Williams, J., Dickerson, M., McMorrow, M., Schrag, S. J., Verani, J. R., Fry, A. M., Azziz-Baumgartner, E., Barron, M. A., Thompson, M. G., & DeSilva, M. B.
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2021-11-05
- Volume
- 70
- Issue
- 44
- Pages
- 1553-1559
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- OpenAlex
- W3209139070
- Cited by
- 172
- References
- 1
- FWCI
- 11.62
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021. https://app.cochat.ai/papers/10.15585/mmwr.mm7044e3
- The paper
- Embi, P. J., Levy, M. E., Naleway, A. L., Patel, P., Gaglani, M., Natarajan, K., Dascomb, K., Ong, T. C., Klein, N. P., Liao, I.-C., Grannis, S. J., Han, J., Stenehjem, E., Dunne, M. M., Lewis, N., Irving, S. A., Rao, S., McEvoy, C., Bozio, C. H., . . . DeSilva, M. B. (2021). Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm7044e3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.